Psychiatry and Neurology, Neurology · Phoenix, AZ
NPI
1093794885
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
3805 E Bell Rd Ste 2400
Phoenix, AZ, 85032
Phone (602) 482-2116
Groups this clinician bills Medicare through
Medicare paid, 2023
$684
18 services
Medicare patients, 2023
18
Average age 73
Drug cost, 2024
$2.4M
966 prescriptions
Company payments, 2025
$31K
From 26 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Lori H Travis was code 99214 (office e&m - established), 15 times for 15 patients. In total Lori H Travis billed 18 services in 3 codes, and Medicare paid $684.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 15 | 15 | $20.92 | $314 |
By year: 2022 $362K for 10,669 services; 2023 $684 for 18 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lori H Travis prescribed most often to Medicare patients was Gabapentin, with 86 prescriptions and refills. In total Lori H Travis wrote 966 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 86 | 194 | 22 | $1,527 |
| Baclofen Generic | 70 | 121 | 18 | $1,444 |
| Levetiracetam Generic | 67 | 139 | 15 | $2,353 |
| Aubagio Teriflunomide | 39 | 43 | Under 11 | $399K |
| Teriflunomide Generic | 36 | 36 | Under 11 | $39K |
| Primidone Generic | 34 | 92 | 13 | $2,208 |
| Memantine Hcl Generic | 32 | 73 | 14 | $866 |
| Armodafinil Generic | 31 | 35 | Under 11 | $1,561 |
| Amitriptyline Hcl Generic | 31 | 89 | Under 11 | $461 |
| Bafiertam Monomethyl Fumarate | 28 | 34 | Under 11 | $230K |
| Emgality Pen Galcanezumab-Gnlm | 28 | 28 | Under 11 | $20K |
| Copaxone Glatiramer Acetate | 26 | 26 | Under 11 | $147K |
| Dalfampridine Er Dalfampridine | 25 | 43 | Under 11 | $5,893 |
| Nurtec Odt Rimegepant Sulfate | 23 | 28 | Under 11 | $51K |
| Clonazepam Generic | 21 | 21 | Under 11 | $206 |
Brand drugs: 285 claims; generic drugs: 681 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lori H Travis $31K ($31K in general payments such as food, travel and fees) from 26 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $21K.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 21 | $21K |
| Amgen Inc. AMGN | 11 | $3,273 |
| TG Therapeutics, Inc. TGTX | 15 | $2,629 |
| Biogen, Inc. BIIB | 45 | $831 |
| Novartis Pharmaceuticals Corporation NVS | 19 | $411 |
| EMD Serono, Inc. MRK.DE | 10 | $379 |
| Abbvie Inc. ABBV | 25 | $362 |
| Genzyme Corporation SNY | 11 | $271 |
| Genentech USA, Inc. ROG.SW | 10 | $267 |
| Argenx US, Inc. ARGX | 11 | $266 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.